Drug Shortage Report for APO-OLOPATADINE

Last updated on 2017-06-30 History
Report ID 11567
Drug Identification Number 02402823
Brand name APO-OLOPATADINE
Common or Proper name OLOPATADINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) OLOPATADINE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 2.5 ML
ATC code S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-29
Estimated end date 2017-06-30
Actual end date 2017-06-29
Shortage status Resolved
Updated date 2017-06-30
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-06-30 English Compare
v6 2017-06-29 French Compare
v5 2017-06-29 English Compare
v4 2017-06-22 French Compare
v3 2017-06-22 English Compare
v2 2017-05-30 French Compare
v1 2017-05-30 English Compare